| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.0094 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.0073 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |